University of California – Los Angeles


University of California – Los Angeles (UCLA) has established a collaborative partnership with multiple universities in the U.S., designating itself as a premier study site for visits. This strategic alliance brings together the research expertise of all institutions, fostering a dedicated environment for the investigation and understanding of CADASIL. Through joint efforts, UCLA and the entire Consortium of sites aim to advance knowledge and contribute to the broader scientific community’s understanding of this rare and complex condition.

David Liebeskind

Position title: Site Principal investigator


Dr. Liebeskind is Professor of Neurology at the University of California, Los Angeles (UCLA) where he is Director of the UCLA Stroke Center. He is Director of the Neurovascular Imaging Research Core, leading global efforts to advance data science and precision medicine of stroke imaging for prevention, acute therapies and recovery after stroke.